AquaBounty Technologies, Inc. (NASDAQ:AQB) Short Interest Update

AquaBounty Technologies, Inc. (NASDAQ:AQB) saw a large decline in short interest in February. As of February 13th, there was short interest totaling 9,108 shares, a decline of 47.4% from the January 29th total of 17,318 shares. Approximately 0.2% of the shares of the stock are sold short. Based on an average daily trading volume, of 34,098 shares, the days-to-cover ratio is presently 0.3 days. Based on an average daily trading volume, of 34,098 shares, the days-to-cover ratio is presently 0.3 days. Approximately 0.2% of the shares of the stock are sold short.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of AquaBounty Technologies in a research note on Monday, December 22nd. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat, AquaBounty Technologies has a consensus rating of “Sell”.

AquaBounty Technologies Trading Up 14.9%

Shares of NASDAQ AQB opened at $1.02 on Friday. The company has a market cap of $3.96 million, a price-to-earnings ratio of -1.23 and a beta of 1.28. AquaBounty Technologies has a 12 month low of $0.50 and a 12 month high of $2.95. The stock has a 50-day moving average price of $0.93 and a two-hundred day moving average price of $1.14.

Institutional Trading of AquaBounty Technologies

An institutional investor recently raised its position in AquaBounty Technologies stock. Renaissance Technologies LLC lifted its position in shares of AquaBounty Technologies, Inc. (NASDAQ:AQB) by 311.9% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 121,585 shares of the company’s stock after purchasing an additional 92,065 shares during the period. Renaissance Technologies LLC owned about 3.14% of AquaBounty Technologies worth $113,000 as of its most recent filing with the Securities and Exchange Commission. 8.92% of the stock is owned by hedge funds and other institutional investors.

About AquaBounty Technologies

AquaBounty Technologies, Inc is a biotechnology company focused on aquaculture innovation through the development and commercialization of genetically engineered fish. Its flagship product, AquAdvantage Salmon, is an Atlantic salmon strain enhanced with a growth hormone gene that enables faster growth and more efficient feed conversion compared with conventional farmed salmon. By integrating biotechnology into seafood production, AquaBounty aims to address global protein demand while reducing the environmental footprint associated with marine aquaculture.

Founded in 1991, AquaBounty is headquartered in Maynard, Massachusetts, and operates a state-of-the-art, land-based incubation and grow-out facility in Panama.